Claim
descriptive

Even though Hashimoto’s disease causes the thyroid to stop working and Graves’ disease causes it to overwork, the immune cells in the thyroid look very similar in both conditions, suggesting the same basic immune processes are at work in both diseases.

Claim Context

Scientific statement

Despite distinct clinical presentations—hypothyroidism in Hashimoto’s thyroiditis and hyperthyroidism in Graves’ disease—both conditions exhibit convergent patterns of immune cell infiltration in thyroid tissue, indicating shared underlying cellular dynamics in autoimmune thyroid disease.

Original statement
We found that, despite markedly different clinical presentations and distinct antigenic triggers, HT and GD exhibit convergent cellular dynamics resulting in a shared continuum of immune infiltration.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

Whether immune cell profiles in thyroid tissue are consistently similar across Hashimoto’s and Graves’ disease across diverse populations and methodologies.

A systematic review and meta-analysis of all published single-cell RNA sequencing and spatial transcriptomics studies of human thyroid tissue from HT and GD patients, standardizing cell type classification, clustering methods, and statistical thresholds to quantify similarity in immune infiltration patterns.

2
Randomized Controlled Trials

Whether inducing immune changes in one disease model alters the immune profile to resemble the other disease.

A double-blind, placebo-controlled trial in 80 patients with early Graves’ disease, randomized to receive a TSH receptor-blocking agent vs. placebo, with serial thyroid biopsies at 0, 6, and 12 months to assess whether immune profile shifts toward that seen in Hashimoto’s.

3
Cohort Studies

Whether patients initially diagnosed with one disease later develop immune profiles resembling the other disease over time.

A prospective cohort study following 300 patients with newly diagnosed Hashimoto’s or Graves’ disease for 10 years, with annual immune profiling of thyroid tissue (via fine-needle aspiration and single-cell sequencing) to track whether immune signatures evolve toward the other disease’s profile.

4
Case-Control Studies

Whether patients with overlapping clinical features (e.g., euthyroid Graves’ or subclinical Hashimoto’s) have immune profiles intermediate between the two classic disease states.

A case-control study comparing immune profiles in 150 patients: 50 with classic Hashimoto’s, 50 with classic Graves’, and 50 with mixed or transitional phenotypes (e.g., euthyroid with high TPO antibodies), using standardized single-cell analysis of thyroid tissue.

5
Cross-Sectional Studies
In Evidence

Whether immune cell composition in thyroid tissue overlaps more between Hashimoto’s and Graves’ than within each disease group.

A cross-sectional analysis of 200 thyroidectomy specimens from patients with Hashimoto’s (n=100) and Graves’ (n=100), with blinded, standardized single-cell RNA sequencing and clustering to compare immune cell proportions and spatial organization.

Sign up to see full verdict